Vmbook Online ordering

Aceto Corp

Aceto Corporation was a publicly traded company listed on the Nasdaq stock exchange under the ticker symbol "ACET" prior to its acquisition. The company, headquartered in New York, was a leading value-added distributor of specialty chemicals and pharmaceutical products in the United States and worldwide.

Aceto's products were used in (1) human health applications, (2) animal health applications, (3) industrial applications, and (4) agricultural applications. Through its subsidiary, Rising Pharmaceuticals, Inc., Aceto also operated as a generic pharmaceutical company in the U.S.

Aceto's revenues for the fiscal year ended June 30, 2018, were $505.9 million, with a net loss of $34.1 million. The company had a market capitalization of approximately $30 million prior to its acquisition.

On November 16, 2018, it was announced that an affiliate of New York-based private investment firm, Aceto's Board of Directors approved a merger agreement with an affiliate of New York-based private investment firm, Century Grove Capital Partners, L.P., under which Aceto would become a private company. Aceto shareholders received $0.94 per share in cash. The transaction closed on January 2, 2019.

Please note, as the acquisition has been completed, the company is no longer publicly traded and no longer provides updates of its financial information to the public.